Latest News about ALKS
Recent news which mentions ALKS
   The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
   
  
  
  November 09, 2021
  From Benzinga
 
   7 A-Rated Healthcare Stocks to Buy for the Long Haul
   
  
  
  November 01, 2021
  From InvestorPlace
 
   10 Biggest Price Target Changes For Thursday
   
  
  
  October 28, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
   
  
  
  October 24, 2021
  From Benzinga
 
   3 Mid-Cap Stocks With Large-Cap Potential
   
  
  
  October 15, 2021
  From InvestorPlace
 
   2 Supercharged Stocks Near 52-Week Highs Despite the Market Pullback
   
  
  
  October 13, 2021
  From Motley Fool
 
   The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
   
  
  
  October 08, 2021
  From Benzinga
 
   The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
   
  
  
  September 29, 2021
  From Benzinga
 
   Benzinga's Bulls And Bears Of The Week: Alibaba, Apple, Nio, PayPal, Verizon And More
   
  
  
  September 04, 2021
  From Benzinga
 
   BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway'
   
  September 02, 2021
  Tickers 
   ALKS
  
  
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021
   
  
  
  September 02, 2021
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Pre-Market Session
   
  
  
  September 02, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
   
  
  
  September 01, 2021
  From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
   
  
  
  August 27, 2021
  From Benzinga
 From Benzinga
 
   Stocks That Hit 52-Week Highs On Monday
   
  
  
  August 23, 2021
  From Benzinga
 
   The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
   
  
  
  August 20, 2021
  From Benzinga
 From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
   
  
  
  August 13, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
   
  
  
  August 06, 2021
  From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
   
  
  
  August 04, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
   
  
  
  August 03, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.